🔴 HCW Biologics Inc is trading 7.4% down today amid broad risk-off sentiment following strong U.S. jobs data

HCW Biologics Inc is trading 7.4% down at $1.51 as small-cap biotech shares face pressure from a broader market sell-off in growth names.

• The move appears aligned with a risk-off reaction to stronger-than-expected U.S. jobs data, which has fueled expectations for higher-for-longer interest rates.
• No company-specific filings, earnings reports, or FDA headlines were identified today to account for the price action.
• The decline follows a volatile week for speculative biotech stocks as investors pivot away from high-growth assets.